BEAM logo Beam Therapeutics : BEAM

BEAM

Stock Data

$30.99

Change down

$0.24 (0.75%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Beam Therapeutics Inc. is a pioneering biotechnology firm based in Cambridge, Massachusetts, focusing on creating precision genetic medicines. The company is at the forefront of developing innovative treatments for serious diseases, including sickle cell disease, beta-thalassemia, severe alpha-1 antitrypsin deficiency, and certain types of leukemia and lymphoma. With a commitment to advancing healthcare through genetic editing, Beam Therapeutics collaborates with industry leaders like Pfizer and Verve Therapeutics to target rare genetic diseases and cardiovascular conditions, showcasing its dedication to transforming patient care.

All Beam Therapeutics Articles

10 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.